PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.

Abstract To investigate the utility of adjuvant hepatic arterial infusion chemotherapy (HAIC) following hepatectomy for patients with hepatocellular carcinoma (HCC) with intrahepatic dissemination (IHD) after local ablation therapy.
PMID
Related Publications

A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.

Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.

Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case.

Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report.

A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.

Authors

Mayor MeshTerms
Keywords

Hepatocellular carcinoma

hepatic arterial infusion chemotherapy

intrahepatic dissemination

local ablation therapy

portal vein tumor thrombosis

Journal Title anticancer research
Publication Year Start




PMID- 29277819
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 38
IP  - 1
DP  - 2018 Jan
TI  - Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for
      Hepatocellular Carcinoma with Intrahepatic Dissemination.
PG  - 525-531
AB  - BACKGROUND/AIM: To investigate the utility of adjuvant hepatic arterial infusion 
      chemotherapy (HAIC) following hepatectomy for patients with hepatocellular
      carcinoma (HCC) with intrahepatic dissemination (IHD) after local ablation
      therapy. PATIENTS AND METHODS: Twelve patients with HCC with IHD were divided
      into two groups: HAIC group (n=6) underwent hepatectomy followed by HAIC; and the
      non-HAIC group (n=6) underwent hepatectomy alone. HAIC with cisplatin and
      5-fluorouracil was started within a month and was continued for a month: Results:
      At the first local ablation, tumors close to the major portal vein and
      insufficient ablation were recognized in eight (67.7%) and six (58.3%) of the
      patients, respectively. In the HAIC group, the 1-, 3-, and 5-year disease-free
      and overall survival rates were 50.0%, 16.7%, and 16.7%, and 83.3%, 83.3% and
      62.5%, respectively. Three patients in the HAIC group remain alive after 10 years
      of follow-up. CONCLUSION: Hepatic resection with short-term postoperative HAIC
      may provide excellent outcomes in patients with HCC and IHD.
CI  - Copyright(c) 2018, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Kuramoto, Kunitaka
AU  - Kuramoto K
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
AD  - Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
FAU - Beppu, Toru
AU  - Beppu T
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
AD  - Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
FAU - Nitta, Hidetoshi
AU  - Nitta H
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Imai, Katsunori
AU  - Imai K
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Masuda, Toshiro
AU  - Masuda T
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Miyata, Tatsunori
AU  - Miyata T
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Koga, Yuki
AU  - Koga Y
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
AD  - Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.
FAU - Kitano, Yuki
AU  - Kitano Y
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Kaida, Takayoshi
AU  - Kaida T
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Nakagawa, Shigeki
AU  - Nakagawa S
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Okabe, Hirohisa
AU  - Okabe H
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Hayashi, Hiromitsu
AU  - Hayashi H
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Hashimoto, Daisuke
AU  - Hashimoto D
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Yamashita, Yo-Ichi
AU  - Yamashita YI
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Chikamoto, Akira
AU  - Chikamoto A
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan.
FAU - Kikuchi, Ken
AU  - Kikuchi K
AD  - Medical Quality Management Center, Kumamoto University Hospital, Kumamoto, Japan.
FAU - Baba, Hideo
AU  - Baba H
AD  - Department of Gastroenterological Surgery, Graduate School of Life Sciences,
      Kumamoto University, Kumamoto, Japan [email protected]
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
RN  - 0 (Antimetabolites, Antineoplastic)
RN  - Q20Q21Q62J (Cisplatin)
RN  - U3P01618RT (Fluorouracil)
SB  - IM
MH  - Aged
MH  - Antimetabolites, Antineoplastic/therapeutic use
MH  - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
MH  - Carcinoma, Hepatocellular/*drug therapy/pathology/*surgery
MH  - Cisplatin/therapeutic use
MH  - Combined Modality Therapy/methods
MH  - Disease-Free Survival
MH  - Female
MH  - Fluorouracil/therapeutic use
MH  - Hepatectomy/*methods
MH  - Hepatic Artery
MH  - Humans
MH  - Infusions, Intra-Arterial
MH  - Liver/pathology
MH  - Liver Neoplasms/*drug therapy/pathology/*surgery
MH  - Male
MH  - Middle Aged
OTO - NOTNLM
OT  - *Hepatocellular carcinoma
OT  - *hepatic arterial infusion chemotherapy
OT  - *intrahepatic dissemination
OT  - *local ablation therapy
OT  - *portal vein tumor thrombosis
EDAT- 2017/12/27 06:00
MHDA- 2018/01/05 06:00
CRDT- 2017/12/27 06:00
PHST- 2017/10/23 00:00 [received]
PHST- 2017/11/09 00:00 [revised]
PHST- 2017/11/10 00:00 [accepted]
PHST- 2017/12/27 06:00 [entrez]
PHST- 2017/12/27 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - 38/1/525 [pii]
AID - 10.21873/anticanres.12254 [doi]
PST - ppublish
SO  - Anticancer Res. 2018 Jan;38(1):525-531. doi: 10.21873/anticanres.12254.